These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 10951612)

  • 1. Does placebo help establish equivalence in trials of new antidepressants?
    Barbui C; Violante A; Garattini S
    Eur Psychiatry; 2000 Jun; 15(4):268-73. PubMed ID: 10951612
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Design of clinical trials of antidepressants: should a placebo control arm be included?
    Fritze J; Möller HJ
    CNS Drugs; 2001; 15(10):755-64. PubMed ID: 11602002
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Study designs and outcomes in antidepressant clinical trials.
    Khan A; Schwartz K
    Essent Psychopharmacol; 2005; 6(4):221-6. PubMed ID: 16041918
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Are antidepressants overrated? A review of methodological problems in antidepressant trials.
    Moncrieff J
    J Nerv Ment Dis; 2001 May; 189(5):288-95. PubMed ID: 11379971
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Are two antidepressant mechanisms better than one? Issues in clinical trial design and analysis.
    Leon AC
    J Clin Psychiatry; 2004; 65 Suppl 4():31-6. PubMed ID: 15046539
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Are placebo controls necessary to test new antidepressants and anxiolytics?
    Khan A; Khan S; Brown WA
    Int J Neuropsychopharmacol; 2002 Sep; 5(3):193-7. PubMed ID: 12366872
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Equivalence trials in SLE research: issues to consider.
    Kim MY; Buyon JP; Petri M; Skovron ML; Shore RE
    Lupus; 1999; 8(8):620-6. PubMed ID: 10568898
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antidepressants using active placebos.
    Moncrieff J; Wessely S; Hardy R
    Cochrane Database Syst Rev; 2001; (2):CD003012. PubMed ID: 11406060
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Complementary and alternative medicine for major depressive disorder: a meta-analysis of patient characteristics, placebo-response rates, and treatment outcomes relative to standard antidepressants.
    Freeman MP; Mischoulon D; Tedeschini E; Goodness T; Cohen LS; Fava M; Papakostas GI
    J Clin Psychiatry; 2010 Jun; 71(6):682-8. PubMed ID: 20573327
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Placebo-controlled antidepressant drug trials. Considering the ethical implications].
    Deisenhammer EA; Hinterhuber H
    Fortschr Neurol Psychiatr; 2003 May; 71(5):243-8. PubMed ID: 12740755
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Does the presence of an open-label antidepressant treatment period influence study outcome in clinical trials examining augmentation/combination strategies in treatment partial responders/nonresponders with major depressive disorder?
    Iovieno N; Papakostas GI
    J Clin Psychiatry; 2012 May; 73(5):676-83. PubMed ID: 22569112
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [What place for placebo in clinical trials conducted on psychiatric patients?].
    Cermolacce M; Belzeaux R; Adida M; Micoulaud Franchi JA; Fakra E; Azorin JM
    Encephale; 2016 Dec; 42(6S):S18-S25. PubMed ID: 28236987
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Exploratory analyses of efficacy data from major depressive disorder trials submitted to the US Food and Drug Administration in support of new drug applications.
    Khin NA; Chen YF; Yang Y; Yang P; Laughren TP
    J Clin Psychiatry; 2011 Apr; 72(4):464-72. PubMed ID: 21527123
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Validity of clinical trials of antidepressants.
    Quitkin FM; Rabkin JG; Gerald J; Davis JM; Klein DF
    Am J Psychiatry; 2000 Mar; 157(3):327-37. PubMed ID: 10698806
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Are placebo controlled studies on the proof of effectiveness of antidepressants necessary?].
    Möller HJ
    Nervenarzt; 2004 May; 75(5):421-4. PubMed ID: 14999463
    [No Abstract]   [Full Text] [Related]  

  • 16. Antidepressants versus placebo for people with bulimia nervosa.
    Bacaltchuk J; Hay P
    Cochrane Database Syst Rev; 2003; (4):CD003391. PubMed ID: 14583971
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Clinical trials using antidepressants and antipsychotics. The pros and cons of placebo control].
    Broich K
    Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2005 May; 48(5):541-7. PubMed ID: 15887064
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Practical issues in equivalence trials.
    Ebbutt AF; Frith L
    Stat Med; 1998 Aug 15-30; 17(15-16):1691-701. PubMed ID: 9749440
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Psychiatry should not become hostage to placebo: an alternative interpretation of antidepressant-placebo differences in the treatment response in depression.
    Rihmer Z; Dome P; Baldwin DS; Gonda X
    Eur Neuropsychopharmacol; 2012 Nov; 22(11):782-6. PubMed ID: 22497852
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A critique of recent studies on placebo effects of antidepressants: importance of research on active placebos.
    Salamone JD
    Psychopharmacology (Berl); 2000 Sep; 152(1):1-6. PubMed ID: 11041309
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.